PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2004 December; 5(4): 145–152.
Published online 2004 August 6. doi:  10.1208/pt050470
PMCID: PMC2750495

Examination of aqueous oxidized cellulose dispersions as a potential drug carrier: II. In vitro and in vivo evaluation of phenylpropanolamine release from microparticles and pellets

Abstract

The purpose of this research is to investigate the release of phenylpropanolamine from oxidized cellulose-phenylpropanolamine (OC-PPA) complexes prepared using aqueous OC dispersions (degree of neutralization, DN, 0–0.44) and phenylpropanolamine-hydrochloride (PPA.HC1) (concentration, 0.5 M or 1.4 M) in vitro and in vivo. The results showed a faster drug release from the OC-PPA complex made using the OC dispersion with a DN value of 0.22 than from those prepared using dispersions with DN values of 0.29 to 0.44. No significant difference existed between the release profiles of OC-PPA microparticles made using OC dispersions with DN values of 0.29 to 0.44 OC-PPA complexes that contained smaller size particles or higher drug levels, or that were processed by freeze drying released PPA faster. Compared with microparticles, the pellets of OC-PPA complexes released PPA more slowly initially. An increase in pH or ionic strength of the dissolution medium increased the release of PPA, which is attributable to increased polymer hydration and solubilization at higher pH and ionic strength conditions. The OC-PPA pellets implanted subcutaneously in rats released 100% of their PPA in 9 to 12 hours. Agood correlation was found between the in vivo and in vitro release data. Tissue pathology results showed no significant inflammatory tissue reactions. In conclusion, the partially ionized aqueous OC dispersions have the potential to be used as an implantable biodegradable carrier for amine drugs.

Keywords: oxidized cellulose, oxycellulose, aqueous oxidized cellulose dispersions, phenylpropanolamine hydrochloride, oxidized cellulose-phenylpropanolamine ionic complex

Full Text

The Full Text of this article is available as a PDF (4.7M).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Yasnitskii BG, Dol'berg EG. Bactericidal hemostatic. USSR patent. 1973;389:794–794.
2. Dol'berg EB, Shuteeva LN, Yasnitskii BG, Obolentseva GV, Khadzha YI, Furmanov YA. Certain aspects of interaction of oxidized cellulose with pharmaceutical compounds. III. Synthesis and biological properties of the product of interaction of oxidized cellulose with kanamycin sulfate. Khim Farm Zh. 1974;8:23–26.
3. Stel'makh VA, Apshchenko MI, Lyakov VVS, Soroka LI. Toxicological characteristics of a lincomycin-containing polymer complex. Ser Biya. Navuk. 1994;2:67–72.
4. Firsov AA, Nazarov AD, Formina IP. Biodegradable implants containing gentamycin: drug release and pharmacokinetics. Drug Dev Ind Pharm. 1987;13(9–11):1651–1674. doi: 10.3109/03639048709068686. [Cross Ref]
5. Sidorenko GI, Gurin AV, Kolyadko MG, Yurkshtovich TI, Nedorezov VL. Antiarrhythmic activity of polymeric formulations of quinidine, trimecaine, ethacizine, propranolol and verapamil. Eksp Klin Farmakol. 1993;56:27–30. [PubMed]
6. Kaputskii FN, Bychkovskii PM, Yurkshtovich TL, Butrim SM, Korolik EV, Buslov DK. Study of photrin sorption by monocarboxycellulose. Colloid J. 1995;57:41–45.
7. Bychkovskii PM, Kaputakii FN, Yurkshtovich TL. Sorption of antitumor drugs by cellulose oxidized by nitrogen(IV) oxide. Ser Khim Navuk. 1993;3:41–45.
8. Zimatkina T, Zimatkin S, Kaputsky F. Antitumor activity of hydroxythiamine and methotrexate immobilized on monocarboxycellulose. Pol J Pharmacol. 2004;48:163–169. [PubMed]
9. Dineen P. Antibacterial activity of oxidized regenerated cellulose. Surg Gynecol Obstet. 1976;142:481–486. [PubMed]
10. Tokunaga YK, Naruse T. Antitumor effect of oxycellulose as a hemostatic during operation. Cancer Biother Radiopharm. 1998;13:437–445. doi: 10.1089/cbr.1998.13.437. [PubMed] [Cross Ref]
11. Giunchedi P, Gavini E, Moretti MD, Pirisino G. Evaluation of alginate compressed matrices as prolonged drug delivery systems. AAPS PharmSciTech. 2000;1:E19–E19. doi: 10.1208/pt010319. [PMC free article] [PubMed] [Cross Ref]
12. United States Pharmacopeial Convention. Phenylpropanolamine Hydrochloride Extended Release Capsules. In:United States Pharmacopeia/National Formulary (USP 23/NF 18). Rockville, MD: United States Pharmacopeial Convention Inc; 1995:2114-2115.
13. Fernandez M, Alvarez-Fuentes J, Iruin A, Holgado MA. In vitro evaluation of a morphine polymeric complex: flowability behavior and dissolution study. AAPS PharmSciTech. 2004;5:E39–E39. doi: 10.1208/pt050339. [PMC free article] [PubMed] [Cross Ref]
14. Irwin WJ, Belaid KA, Alpar HO. Drug-delivery by ion-exchange. III: Interaction of ester prodrugs of propranolol with cationic exchange resins. Drug Dev Ind Pharm. 1987;13(9–11):2047–2066. doi: 10.3109/03639048709068706. [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists